Investigation Overview
According to a press release an investigation on behalf of NitroMed, Inc. (NASDAQ: NTMD) investors over possible breaches of fiduciary duty and other violations of state law by the board of directors of NitroMed arising out of their attempt to sell the NitroMed to Deerfield Capital. NitroMed, Inc. (NASDAQ: NTMD) announced that it entered into a merger agreement to be acquired by aff...
You must register (for free) or login to view the entire investigation.